Age, sex, and overall
health are predictors of outcome after hospitalization with first
episode of heart failure
Age, sex, and overall health predict survival in patients with an
initial hospitalization for heart failure, according to an article
in the Aug 12th issue of the Archives of Internal Medicine. Researchers
studied data from 38,702 patients, including status at 30 days and
1 year after discharge. Mortality rates rose sharply with age both
at 30 days and 1 year after discharge. Men and women had similar survival
at 30 days, but women showed a roughly 20 percent higher survival
rate at 1 year. The presence of comorbid conditions was strongly predictive
of survival. The authors postulate that survival rates in clinical
trials are higher because of selection bias, and they urge further
study of the total population of patients with heart failure.
Full Text: Age, sex, and overall health are predictors of survival
among patients hospitalized for the first time for heart failure,
according to an article in the Aug 12th issue of The Archives of
Internal Medicine.
According to background
information cited in the article, the mortality rate due to heart
failure in patients involved in clinical trials have decreased over
the past decade, but the prognosis of patients not involved in trials
who have had an initial hospitalization for heart failure has not
been well studied.
Jack V. Tu, M.D.,
Ph.D., and his Canadian colleagues analyzed hospital records of
38,702 patients admitted for the first time for heart failure from
April 1994 through March 1997 in Ontario, Canada. The records contained
information on age, sex, and health variables of each patient including
comorbid conditions. Health status at 30 days and 1 year after hospital
discharge were determined through linkage with the Ontario Registered
Persons Database. The information was analyzed to identify relations
among survival, age, sex, and other illnesses.
The 30-day and
1-year death rates after discharge for a first heart failure admission
were 11.6 percent and 33.1 percent, respectively. The authors found
that mortality rates rose sharply with age. The 30-day death rate
rose from 4.5 percent in those younger than 50 years to 15.1 percent
in patients 75 years or older. Death rates at 1 year after discharge
were 13.5 percent in patients younger than 50 years compared with
40.1 percent in patients 75 years or older.
Men and women had
similar survival at 30 days, but women showed a roughly 20 percent
higher survival rate at 1 year. Diseases such as cancer, kidney
disease, dementia, cerebrovascular disease, rheumatologic diseases,
and diabetes were all linked with higher mortality rates both at
30 days and 1 year after discharge.
The authors write
that "Only young subjects with minimal comorbidity had the
low mortality rates seen in contemporary clinical trials of heart
failure. For most community-dwelling subjects with heart failure
who were more likely to be older women with significant comorbidities,
their prognosis remained poor."
They note that
"The large disparity between [death] rates observed in our
study and those reported in clinical trials is due to selection
bias of the populations enrolled in these trials. Contemporary clinical
trials of heart failure have largely been conducted in white, male
populations with mean ages of about 60 years and a minimal number
of comorbidities."
The authors conclude
that their study indicates that "much more remains to be done
to improve the outcomes of this seriously ill population..."
|